Delivery Order SPE2DB20D3505-SPE2DB25FT4S3
Award Date
11/21/24
Potential Completion Date
11/22/24
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,240.34, is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,039.26, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,295.49, is for the delivery of Dupixent 300 mg/2 ml pens. The contract is a delivery order with a firm fixed price and an ultimate completion date of March 13, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,690.20, is for the delivery of Dupixent 300 mg/2 ml pens. It is a firm fixed-price delivery order contract with a completion date of March 13, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a pharmaceutical product, with a ceiling value of $12,634.70. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 16, 2025. The contract is not set aside and is open to competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen (2 ml), a specialty pharmaceutical product. The award has a ceiling value of $13,393.79 and an ultimate completion date of October 18, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,146.60, is for the delivery of 4,567,137,177 units of Dupixent 300 mg/2 ml pen. The contract has a period of performance through February 4, 2025 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,453.77, is for the delivery of Dupixent 300 mg/2 ml pens. It is a firm fixed-price delivery order with a completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,789.41, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a prescription medication. The fixed-price delivery order has a ceiling value of $27,344.64 and a completion date of June 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...